Variations in Surgeon Volume and Use of Pelvic Lymph Node Dissection with Open and Minimally Invasive Radical Prostatectomy

Urology

Volumn 72, Issue 3, 2008, Pages 647-652

  Prasad, Sandip M ^a   Keating, Nancy L ^a,b   Wang, Qin ^c   Pashos, Chris L ^c   Lipsitz, Stuart ^a   Richie, Jerome P ^a,d   Hu, Jim C ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Dana Farber Cancer Institute ^*

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COMORBIDITY; CONFIDENCE INTERVAL; DEMOGRAPHY; GEOGRAPHIC DISTRIBUTION; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURGEON;

AGED; AGED, 80 AND OVER; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; NEOPLASM STAGING; ODDS RATIO; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; TREATMENT OUTCOME; UROLOGIC SURGICAL PROCEDURES; UROLOGY;

EID: 50249086508     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.03.067     Document Type: Article

References (19)

1. Zincke H., Lau W., Bergstralh E., et al. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. J Urol 166 (2001) 2208-2215
2. Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: The 15-year Johns Hopkins experience. Urol Clin North Am 28 (2001) 555-565
3. Bishoff J.T., Reyes A., Thompson I.M., et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: Development of a system of patient selection. Urology 45 (1995) 270-274
4. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int 98 (2006) 788-793
5. Cooperberg M.R., Lubeck D.P., Meng M.V., et al. The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management. J Clin Oncol 22 (2004) 2141-2149
6. Romano P.S., Roos L.L., and Jollis J.G. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 46 (1993) 1075-1079
7. Nuttall M., van der Meulen J., Phillips N., et al. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures. J Urol 172 (2004) 2145-2152
8. Ahlering T.E., Skarecky D., Lee D., et al. Successful transfer of open surgical skills to a laparoscopic environment using a robotic interface: Initial experience with laparoscopic radical prostatectomy. J Urol 170 (2003) 1738-1741
9. Lotan Y., Cadeddu J.A., and Gettman M.T. The new economics of radical prostatectomy: Cost comparison of open, laparoscopic and robot assisted techniques. J Urol 172 (2004) 1431-1435
10. Haese A., Epstein J.I., Huland H., et al. Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma. Cancer 95 (2002) 1016-1021
11. Campbell S.C., Klein E.A., Levin H.S., et al. Open pelvic lymph node dissection for prostate cancer: A reassessment. Urology 46 (1995) 352-355
12. Mettlin C. The American Cancer Society National Prostate Cancer Detection Project and national patterns of prostate cancer detection and treatment. CA Cancer J Clin 47 (1997) 265-272
13. Denberg T.D., Flanigan R.C., Kim F.J., et al. Self-reported volume of radical prostatectomies among urologists in the USA. BJU Int 99 (2007) 339-343
14. Begg C.B., Riedel E.R., Bach P.B., et al. Variations in morbidity after radical prostatectomy. N Engl J Med 346 (2002) 1138-1144
15. Hu J.C., Gold K.F., Pashos C.L., et al. Temporal trends in radical prostatectomy complications from 1991 to 1998. J Urol 169 (2003) 1443-1448
16. Lu-Yao G.L., McLerran D., Wasson J., et al., Prostate Patient Outcomes Research Team. An assessment of radical prostatectomy: Time trends, geographic variation, and outcomes. JAMA 269 (1993) 2633-2636
17. Paquette E.L., Sun L., Paquette L.R., et al. Improved prostate cancer-specific survival and other disease parameters: Impact of prostate-specific antigen testing. Urology 60 (2002) 756-759
18. Berglund R.K., Sadetsky N., DuChane J., et al. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: Results from CaPSURE. J Urol 177 (2007) 526-529
19. Clark T., Parekh D.J., Cookson M.S., et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169 (2003) 145-147